The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gaydukova I.Z.

Mechnikov North-West State Medical University, St. Petersburg, Russia

Mazurov V.I.

North-Western State Medical University named after I.I. Mechnikov, St.-Petersburg, Russia

The efficacy of non-sreroidal anti-inflammatory drugs

Authors:

Gaydukova I.Z., Mazurov V.I.

More about the authors

Read: 4989 times


To cite this article:

Gaydukova IZ, Mazurov VI. The efficacy of non-sreroidal anti-inflammatory drugs. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(5):134‑140. (In Russ.)
https://doi.org/10.17116/jnevro2019119051134

Recommended articles:

References:

  1. Karateev AE, Nasonov EL, Ivashkin VT, Martynov AI, Yakhno NN, Arutyunov GP, Alekseeva LI, Abuzarova GR, Evseev MA, Kukushkin ML, Kopenkin SS, Lila AM, Lapina TL, Novikova DS, Popkova TV, Rebrov AP, Skorobogatykh KV, Chichasova NV; Association of Rheumatologists of Russia, Russian Society for the Study of Pain, Russian Gastroenterology Association, Russian Scientific Medical Society of Therapists, Association of Traumatologists and Orthopedists of Russia, Russian Association of Palliative Medicine. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2018;56(1):1-29. (In Russ.) https://doi.org/10.14412/1995-4484-2018-1-29
  2. Mazurov VI, Trofimov EA, Lesnyak OM, Belyaeva IB. Rheumatology. Pharmacotherapy without errors. A guide for doctors. By ed. Mazurov V.I., Lesnyak O.M. M.: E-noto; 2017. (In Russ.)
  3. van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978-991. https://doi.org/10.1136/annrheumdis-2016-210770
  4. Steinmeyer J, Bock F, Stöve J, Jerosch J, Flechtenmacher J. Pharmacological treatment of knee osteoarthritis: Special considerations of the new German guideline. Orthop Rev (Pavia). 2018;10(4):7782. eCollection 2018 Dec 6. https://doi.org/10.4081/or.2018.7782
  5. da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, Trelle S. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2016;387:2093-2105. https://doi.org/10.1016/S0140-6736(17)31744-0
  6. European Medicines Evaluation Agency (EMEA): Public assessment report for medicinal products containing non-selective non steroidal antiinflammatory drugs (NSAIDs). Published on 07/11/2006. Accessed on 20.03.2018. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2010/01/WC500054344.pdf
  7. Schoels MM, Braun J, Dougados M, Emery P, Fitzgerald O, Kavanaugh A, Kvien TK, Landewé R, Luger T, Mease P, Olivieri I, Reveille J, Ritchlin C, Rudwaleit M, Sieper J, Smolen JS, Wit Md, van der Heijde D. Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis. Ann Rheum Dis. 2014;73(1):238-242. https://doi.org/10.1136/annrheumdis-2013-203860
  8. Wendling D. Treating to target in axial spondyloarthritis: defining the target and the arrow. Expert Rev Clin Immunol. 2015;11(6):691-693. https://doi.org/10.1586/1744666X.2015.1039514
  9. Gaidukova IZ, Rebrov AP, Otteva EN, Badokin VV, Bochkova AG, Bugrova OV, Godzenko AA, Dubikov AA, Ivanova ON, Korotaeva TV, Lapshina SA, Nesmeyanova OB, Nikishina I.P., Raskin TA, Rumyantseva TA, Smirnov AV, Sitalo AV, Erdes ShF. Use of nonsteroidal anti-inflammatory drugs for the treatment of axial spondyloarthritis, including ankylosing spondylitis, monitoring their efficacy and safety (draft guidelines of the Expert Spondyloarthritis Diagnosis and Treatment Group). Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016;54(1):67-74. (In Russ.) https://doi.org/10.14412/1995-4484-2016-1S-67-74
  10. Gaidukova IZ, Rebrov AP, Aparkina AV. Efficacy and safety of using nimesulide (Nemulex) in patients with active ankylosing spondylitis who have not achieved remission or low activity with other NSAIDs. RMJ. 2015;23(7):378-381. (In Russ.)
  11. Xu S, Rouzer CA, Marnett LJ. Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond. IUBMB Life. 2014;66(12):803-811. Epub 2014 Dec 23. https://doi.org/10.1002/iub.1334
  12. Timmers L, Pasterkamp G, de Kleijn DP. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases? Mol Interv. 2007;7(4):195-199, 180.
  13. Ross WB, Leaver HA, Yap PL, Raab GM, Su BH, Carter DC. Prostaglandin E2 production by rat peritoneal macrophages: role of cellular and humoral factors in vivo in transfusion-associated immunosuppression. FEMS Microbiol Immunol. 1990;2:321-325.
  14. Murakami M, Nakashima K, Kamei D, Masuda S, Ishikawa Y, Ishii T. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem. 2003;278:37937-37947.
  15. Na YR, Yoon YN, Son DI, Seok SH. Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model. PLoS One. 2013;8(5):e63451. Published online 2013 May 7. https://doi.org/10.1371/journal.pone.0063451
  16. Kumagai K, Kubo M, Imai S, Toyoda F, Maeda T, Okumura N, Matsuura H, Matsusue Y. The COX-2 Selective Blocker Etodolac Inhibits TNFα-Induced Apoptosis in Isolated Rabbit Articular Chondrocytes. Int J Mol Sci. 2013;14(10):19705-19715. Published online 2013 Sep 30. https://doi.org/10.3390/ijms141019705
  17. Dong X, Li R, Xiu P, Dong X, Xu Z, Zhai B, Liu F, Jiang H, Sun X, Li J, Qiao H. Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways. PLoS One. 2014;9(3):e92864. Published online 2014 Mar 27. https://doi.org/10.1371/journal.pone.0092864
  18. Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J.Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70(8):1369-1374. https://doi.org/10.1136/ard.2010.145995
  19. Wanders A, Heijde Dv, Landewé R, Béhier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52:1756-1765. https://doi.org/10.1002/art.21054
  20. Sim ZH, Pinard CL, Plattner BL, Bienzle D. Cyclooxygenase-2 expression in the eyes of cats with and without uveitis. Am J Vet Res. 2018;79(1):90-97. https://doi.org/10.2460/ajvr.79.1.90
  21. Kern MA, Schubert D, Sahi D, Schöneweiss MM, Moll I, Haugg AM, Dienes HP, Breuhahn K, Schirmacher P. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology. 2002;36:885-894. https://doi.org/10.1053/jhep.2002.36125
  22. Sieper J, Listing J, Poddubnyy D., Song IH, Hermann KG, Callhoff J, Syrbe U, Braun J, Rudwaleit M. Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). Ann Rheum Dis. 2016;75:1438-1443. [PubMed]. https://doi.org/10.1136/annrheumdis-2015-207897
  23. Wanders A, Heijde Dv, Landewé R, Béhier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52(6):1756-1765. https://doi.org/10.1002/art.21054
  24. Gaydukova IZ, Rebrov AP, Nam IF, Kirsanova NV. Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis. Therapeutic Archive. 2014;86(12):42-47. (In Russ.) https://doi.org/10.17116/terarkh2014861242-47
  25. Gaidukova IZ, Rebrov AP, Lapshina SA, Otteva EN, Dubinina TV, Badokin VV, Bochkova AG, Bugrova OV, Godzenko AA, Dubikov AI, Ivanova ON, Korotaeva TV, Nesmeyanova OB, Nikishina IP, Raskina TA, Rumyantseva OA, Smirnov AV, Sitalo AV, Erdes ShF. Use of nonsteroidal anti-inflammatory drugs and biological agents for the treatment of axial spondyloarthritides. Recommendations of the Spondyloarthritis Study Group of Experts, All-Russian Public Organization «The Association of Rheumatology of Russia». Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017;55(5):474-484. (In Russ.) https://doi.org/10.14412/1995-4484-2017-474-484
  26. Karateev AE, Lila AM, Pogozheva EYu, Amirdzhanova VN. The efficacy of meloxicam in acute back pain: results of an observational non-interventional multicenter study. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2018;118(6):24-30. (In Russ.) https://doi.org/10.17116/jnevro20181186124
  27. Lewis SC, Langman MJS, Laporte JR. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANS AIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Brit J Clin Pharm. 2002;54:320-326.
  28. Gaidukova IZ, Rebrov AP. Efficacy and safety of different prescribing regimens for patients with axial spondyloarthritis, including ankylosing spondylitis. Therapeutic Archive. 2015;87(3):77-82. (In Russ.) https://doi.org/10.17116/terarkh201587377-82
  29. Bichurina DM, Gaydukova IZ, Rebrov AP. Efficacy and renal safety of meloxicam in patients with degenerative-dystrophic diseases of the spine: the results of the scientific program «Moment». Bulletin of the North-West State Medical University I.I. Mechnikov. 2018;10(4):31-36. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.